Literature DB >> 10099311

Fluxes and enzyme activities in central metabolism of myeloma cells grown in chemostat culture.

N Vriezen1, J P van Dijken.   

Abstract

Activities of enzymes in glycolysis, the pentose phosphate pathway, the tricarboxylic acid cycle, and glutaminolysis have been determined in the mouse myeloma SP2/0.Ag14. Cells were grown on IMDM medium with 5% serum in steady-state chemostat culture at a fixed dilution rate of 0.03 h-1. Three culture conditions, which differed in supply of glucose and oxygen, were chosen so as to change catabolic fluxes in the central metabolism, while keeping anabolic fluxes constant. In the three steady-state situations, the ratio between specific rates of glucose and glutamine consumption differed by more than twentyfold. The specific rates of glucose consumption and lactate production were highest at low oxygen supply, whereas the specific rate of glutamine consumption was highest in the culture fed with low amounts of glucose. Under low oxygen conditions, the specific production of ammonia increased and the consumption pattern of amino acids showed large changes compared with the other two cultures. For the three steady states, activities of key enzymes in glycolysis, the pentose phosphate pathway, glutaminolysis, and the TCA cycle were measured. The differences in the in vivo fluxes were only partially reflected in changes in enzyme levels. The largest differences were observed in the levels of glycolytic enzymes, which were elevated under conditions of low oxygen supply. High activities of phosphoenolpyruvate carboxykinase (E.C. 4.1.1.32) in all cultures suggest an important role for this enzyme as a link between glutaminolysis and glycolysis. For all enzymes, in vitro activities were found that could accommodate the estimated maximum in vivo fluxes. These results show that the regulation of fluxes in central metabolism of mammalian cells occurs mainly through modulation of enzyme activity and, to a much lesser extent, by enzyme synthesis. Copyright 1998 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10099311     DOI: 10.1002/(sici)1097-0290(19980705)59:1<28::aid-bit5>3.0.co;2-v

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

1.  Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma.

Authors:  Francesca Fontana; Xia Ge; Xinming Su; Deep Hathi; Jingyu Xiang; Simone Cenci; Roberto Civitelli; Kooresh I Shoghi; Walter J Akers; Andre D'avignon; Katherine N Weilbaecher; Monica Shokeen
Journal:  Clin Cancer Res       Date:  2016-08-02       Impact factor: 12.531

Review 2.  Advanced stoichiometric analysis of metabolic networks of mammalian systems.

Authors:  Mehmet A Orman; Francois Berthiaume; Ioannis P Androulakis; Marianthi G Ierapetritou
Journal:  Crit Rev Biomed Eng       Date:  2011

3.  Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.

Authors:  S Mazurek; W Zwerschke; P Jansen-Dürr; E Eigenbrodt
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

4.  Characterisation of G418-induced metabolic load in recombinant CHO and BHK cells: effect on the activity and expression of central metabolic enzymes.

Authors:  C A Yallop; P L Nørby; R Jensen; H Reinbach; I Svendsen
Journal:  Cytotechnology       Date:  2003-07       Impact factor: 2.058

5.  Metabolic characteristics of recombinant Chinese hamster ovary cells expressing glutamine synthetase in presence and absence of glutamine.

Authors:  Fang Zhang; Xiangming Sun; Xiaoping Yi; Yuanxing Zhang
Journal:  Cytotechnology       Date:  2006-08-05       Impact factor: 2.058

6.  Metabolic-flux analysis of hybridoma cells under oxidative and reductive stress using mass balances.

Authors:  H P Bonarius; J H Houtman; G Schmid; C D de Gooijer; J Tramper
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.